Purpose/Objectives: To review the phenomenon of direct-to-consumer (DTC) advertising of prescription medications in the media, with an overview of pertinent studies in the literature regarding patients' and healthcare professionals' perspectives on DTC advertising.
Data Sources: Journal articles, media, and clinical experience.
Data Synthesis: DTC advertising of prescription medications is extremely prevalent in U.S. society. Advertising of medications is an expensive business; yearly spending is expected to reach $7.5 billion by 2005. Although opinions vary regarding DTC advertising, healthcare professionals, including oncology nurses, must be prepared to discuss DTC-advertised medications and treatments with their patients.
Conclusions: Communication is the key to helping patients decipher the deluge of DTC advertisements in the media and determine the accuracy of this ever-increasing source of medical information.
Implications for Nursing: Oncology nurses need to be aware of the increases in DTC advertising of prescription medications and the importance of guiding patients through appropriate medication choices by education.
Alper, P.R. (1999). Direct to consumer advertising: Education or anathema? [Letter to the editor]. JAMA, 282, 1226--1227. Retrieved July 13, 2001 from http://jama.ama-assn.org/issues/v282m13/ffull/jlt1006--4.html
American Cancer Society. (2002). Cancer facts and figures. Atlanta: Author.
Anderson, E.R. (2001). AMA letter to Senator Peter Fitzgerald (R-IL) regarding direct-to-consumer advertising of prescription drugs. Retrieved July 13, 2001 from http://ama-assn.org/ama/pub/article/4051--4805.html
Baylor-Henry, M., & Drezin, N.A. (1998). Regulation of prescription drug promotion: Direct-to-consumer advertising. Clinical Therapeutics, 20(Suppl. C), C86-C95.
Bell, R.A., Kravitz, R.L., & Wilkes, M.S. (1999). Direct-to-consumer prescription drug advertising and the public. Journal of General Internal Medicine, 14, 651--657.
Bell, R.A., Kravitz, R.L., & Wilkes, M.S. (2000). Direct-to-consumer prescription drug advertising, 1989--1998: A content analysis of conditions, targets, inducements, and appeals. Journal of Family Practice, 49, 329--335.
Bell, R.A., Wilkes, M.S., & Kravitz, R.L. (1999). Advertisement-induced prescription drug requests: Patient's anticipated reactions to a physician who refuses. Journal of Family Practice, 48, 446--452.
Bell, R.A., Wilkes, M.S., & Kravitz, R.L. (2000). The educational value of consumer-targeted prescription drug print advertising. Journal of Family Practice, 49, 1092--1098.
Berger, J.T., Kark, P., Rosner, F., Packer, S., & Bennett, A.J. (2001). Direct-to-consumer drug marketing: Public service or disservice? Mount Sinai Journal of Medicine, 68, 197--202.
Berkowitz, L., Capizzi, M.D., Breuer, J., & Szuminski, J. (April, 2001). Internet DTC: Minding your Ps and Qs. Pharmaceutical Executive, 21 (4), 124--130.
Carroll-Johnson, R.M. (2001). Finding information in all the wrong places [Editorial]. Oncology Nursing Forum, 28, 787.
Clark, P.M., & Gomez, E.G. (2001). Details on demand: Consumers, cancer information, and the Internet. Clinical Journal of Oncology Nursing, 5, 19--24.
Davis, J.J. (2000). Riskier than we think? The relationship between risk statement completeness and perceptions of direct-to-consumer advertisement of prescription drugs. Journal of Health Communication, 5, 349--369.
Elliot, V.S. (2001). Questions swirl around drug ads for patients. Retrieved July 12, 2001 from http://www.ama-assn.org/sci-pubs/amnews/pick_01/hll10709.htm
Findlay, S.D. (2001). Direct-to-consumer promotion of prescription drugs. Economic implications for patients, payers, and providers. Pharmacoeconomics, 19, 109--119.
Goldblatt, D., Beresford, H.R., Bernat, J.L., Mackin, G.A., McQuillen, M.P., Nelson, R.F., et al. (2001). Practice advisory: Participation of neurologists in direct-to-consumer advertising. Neurology, 56, 995--996.
Gonul, F.F., Carter, F., & Wind, J. (2000). What kind of patients and physicians value direct-to-consumer advertising of prescription drugs? Health Care Management Science, 3, 215--226.
Goodman, E. (2001, July 21). Side effects may include pain in the pocket-book (Editorial). San Jose Mercury News, p. 7b.
Hall, S.S. (2001, March 11). Prescription for profit. New York Times Magazine, pp. 40--45, 59, 91--92, 103.
Henney, J.E. (2000). Challenges in regulating direct-to-consumer advertising. MSJAMA online, 284, 2242. Retrieved July 12, 2001 from http:// www.ama-assn.org/sci-pubs/msjama/articles/vol-284/no-17/ jms00030.htm
Hoffman, J.R., & Wilkes, M. (1999). Direct-to-consumer advertising of prescription drugs [Editorial]. BMJ, 318, 1301--1302.
Hollon, M.F. (1999). Direct-to-consumer marketing of prescription drugs: Creating consumer demand. JAMA, 281, 382--384.
Holmer, A.F. (1999). Direct-to-consumer prescription drug advertising builds bridges between patients and physicians. JAMA, 281, 380--382.
Huang, A.J. (2000). The rise of direct-to-consumer advertising of prescription drugs in the United States. JAMA, 284, 2240.
Kravitz, R.L. (2000a). Direct-to-consumer advertising of prescription drugs. Western Journal of Medicine, 173, 221--222.
Kravitz, R.L. (2000b). Direct-to-consumer advertising of prescription drugs: Implications for the patient-physician relationship. JAMA, 284, 2244.
Lee, R. (2001). Direct-to-consumer advertising: Pharmacoeconomics. Orthopedic Technology Review, 3(1), 30--34.
Lipsky, M.S., & Taylor, C.A. (1997). The opinions and experiences of family physicians regarding direct-to-consumer advertising. Journal of Family Practice, 45, 495--499.
Moynihan, R., Bero, L., Ross-Degnan, D., Henry, D., Lee, K., Watkins, J., et al. (2000). Coverage by the news media of the benefits and risks of medications. New England Journal of Medicine, 342, 1645--1650.
PDR Getting Well Network. (2001a). Breast cancer. Retrieved July 21, 2001 from http://www.pdr.net/gettingwell/breast_cancer/index.html
PDR Getting Well Network. (2001b). Depression. Retrieved July 21, 2001 from http://www.pdr.net/gettingwell/depression/index.html
Peters, J. (2001). The high cost of direct-to-consumer advertising. Minnesota Medicine, 84 (1), 10--15.
Pines, W.L. (1998). Direct-to-consumer promotion: An industry perspective. Clinical Therapeutics, 20(Suppl. C), C96-C103.
Pines, W.L. (2000). Direct-to-consumer advertising. Annals of Pharmacotherapy, 34, 1341--1344.
Read, J.O. (2001). DTC advertising: Obstacle or opportunity. Minnesota Medicine, 84(1), 12--13.
Reeves, K.N. (1998). Direct-to-consumer broadcast advertising: Empowering the consumer or manipulating a vulnerable population? Food and Drug Law Journal, 53, 661--679.
Rosner, F., Kark, P., Packer, S., Bennett, A., & Berger, J. (1999). Direct-to-consumer advertising: Education or anathema? [Letter to the editor]. JAMA, 282, 1227. Retrieved July 13, 2001 from http://jama.ama-assn.org/issues/v282m13/ffull/jlt1006--4.html
Sansgiry, S., Sharp, W.T., & Sansgiry, S.S. (1999). Accuracy of information on printed over-the-counter drug advertisements. Health Mark Q, 17 (2), 7--18.
Sellers, J.A. (2000). The two faces of direct-to-consumer advertising [Editorial]. American Journal Health-System Pharmacy, 57, 1401.
Spurgeon, D. (1999). Doctors feel pressurised by direct to consumer advertising. BMJ, 319, 1321.
Steinman, M.A. (2000). Gifts to physicians in the consumer-marketing era. JAMA, 284, 2243.
Tanne, J.H. (1999). Direct-to-consumer drug advertising is billion-dollar business in U.S. British Medical Journal, 319, 805.
U.S. Food and Drug Administration, Center for Drug Evaluation and Research. (1999). Guidance for industry: Consumer-directed broadcast advertisements. Retrieved August 21, 2001 from http://www.fda.gov/ cder/guidance/1804q&a.htm
U.S. Food and Drug Administration, Center for Drug Evaluation and Research. (2001a). Attitudes and behaviors associated with direct-to-consumer (DTC) promotion of prescription drugs: Main survey results. Retrieved July 12, 2001 from http://www.fda.gov/cder/ddmac/dtcindex.htm
U.S. Food and Drug Administration, Center for Drug Evaluation and Research. (2001b). Guidance for industry: Using FDA-approved labeling in consumer-directed print advertisements [Draft]. Retrieved October 1, 2001 from http://www.fda.gov/cder/guidance/4114dft.pdf.